Principles of Disease and Epidemiology – Chapter 14

Epidemiology

• Definition: study of disease patterns in populations (distribution, determinants, frequency).
• Practical roles of epidemiologists:
  • Design infection-control strategies.
  • Predict, monitor and help prevent the spread of disease.
  • Supply data critical for public-health policy.

Fundamental Terminology (Pathology, Infection & Disease)

• \text{Pathology}: discipline that investigates every aspect of disease.
• \text{Etiology}: specific cause of a disease.
  • In infectious diseases, the etiological agent = the pathogen.
• \text{Pathogenesis}: step-by-step development of a disease from initial contact → final outcome.
• \text{Infection}:
  • Invasion + colonisation of host tissues by pathogens.
  • Distinct from mere “colonisation” by normal microbiota because, under normal conditions, commensals cause no harm.
• \text{Disease}: An abnormal state in which normal body functions are disrupted; often (but not always) preceded by infection.

Normal vs. Transient Microbiota

• \text{Normal (Resident) Microbiota}
  • Permanent, life-long members of the host.
  • Typically harmless; can become pathogenic in an immunocompromised host or when displaced.
• \text{Transient Microbiota}
  • Temporary; present for days → months, then disappear.
• \text{Opportunistic Microorganisms}
  • Normally benign but can exploit altered host conditions (immunity ↓, dysbiosis, entry into sterile sites) to cause disease.

Symbiotic Relationships

• \text{Commensalism}: one organism benefits, the other unaffected. Example – skin Staphylococcus \text{epidermidis}.
• \text{Mutualism}: both partners benefit. Example – E.\,coli in colon synthesising vitamin K while receiving nutrients/ habitat.
• \text{Parasitism}: one benefits at expense of host (i.e., classical pathogens).

Dynamics of the Normal Microbiota

• Highly variable; influenced by diet, hormones, age, antibiotics, stress, lifestyle.
• Body regions with resident microbes vs. completely sterile sites (e.g., bloodstream, cerebrospinal fluid, deep tissues).
• Site displacement ⇒ infections (e.g., intestinal E.\,coli entering urinary tract → UTI).
• Imbalance/overgrowth = \text{Dysbiosis}.
  • Correlated with inflammatory bowel disease, chronic fatigue syndrome, and other conditions.

Acquisition of Normal Microbiota

• In utero: historically considered sterile; recent data suggest limited exposure possible.
• Birth passage – first major inoculation (vaginal deliveries vs. C-section difference).
• Post-natal sources: environment, food, caregivers, clothing.
• NIH “Human Microbiome Project” offers genomic catalogues.

Representative Body-Site Communities (FYI – not for memorisation)

• Skin: Propionibacterium, Staphylococcus, Corynebacterium, Micrococcus, yeasts (Candida, Malassezia).
  • Barriers: keratin, sweat/oil antimicrobials, low pH, low moisture.
• Eyes (conjunctiva): essentially skin microbiota; tears/blinking mechanically & chemically limit colonisation.
• Nose/Throat: Staph. aureus/epidermidis, Streptococcus pneumoniae, Haemophilus, Neisseria; mucus & ciliary escalator + antagonism hold pathogens in check.
• Mouth: dense biofilms – Streptococcus, Lactobacillus, Actinomyces, Bacteroides, Veillonella, etc.; saliva flushing & antimicrobials moderate populations.
• Large Intestine: largest biomass (E. coli, Bacteroides, Bifidobacterium, Enterococcus…); mucus shedding & diarrhoea prevent over-attachment.
• Urogenital: distinct flora in urethra & vagina (lactobacilli, staphylococci, Candida, Trichomonas). Urine flow, low pH, mucus shedding = defence.

Microbial Antagonism (Competitive Exclusion)

• Resident microbiota defend host by:
  1. Competing with pathogens for nutrients.
  2. Producing bacteriocins / acids toxic to invaders but harmless to host.
  3. Altering local pH & O_2 tension → unfavourable for newcomers.

Koch’s Contribution: Determining Etiology of Infectious Diseases

• Purpose: experimentally link a specific microbe to a specific disease – cornerstone for diagnosis, therapy & prevention.

Koch’s Postulates (Classic Form)

• 1. The same pathogen must be present in every case of the disease.
• 2. The pathogen must be isolated from the diseased host and grown in pure culture.
• 3. The cultured pathogen must cause the same disease when inoculated into a healthy, susceptible animal.
• 4. The pathogen must be re-isolated from the experimentally infected animal and shown to be identical to the original organism.

Experimental Workflow Visualised

1. Isolate microbes from diseased/dead animal → obtain colonies.
2. Identify & grow in pure culture.
3. Inoculate healthy test animal.
4. Observe reproduction of disease.
5. Re-isolate + re-identify the microbe (must match original).

Limitations / Exceptions

• One pathogen → multiple clinical syndromes (e.g., Streptococcus\,pyogenes causing strep throat, scarlet fever, skin infections).
• Some agents are human-exclusive; ethical barriers prevent animal inoculation (e.g., Treponema\,pallidum, HIV).
• Certain microbes refuse in-vitro culture (obligate intracellular pathogens like Chlamydia, viruses).
• Polymicrobial diseases & microbiome-related conditions complicate single-agent attribution.

Integration & Real-World Relevance

• Epidemiology + Koch’s postulates lay foundations for outbreak investigation, antimicrobial therapy choice, vaccine design.
• Dysbiosis research reshapes understanding of chronic inflammatory, metabolic and neuropsychiatric diseases.
• Awareness of normal microbiota influences clinical practices: probiotic use, antibiotic stewardship, C-section vs. vaginal delivery considerations.
• Ethical / philosophical implication: defining “health” now includes microbial ecology, blurring line between self and symbiont.